Promising Test Results For Its Cancer Drugs Just Launched This Small Biotech To A Record High
On Monday, the small biotech stock highlighted in today’s article hit a record high, skyrocketing 95.1%. The catalyst?
Best Penny Stocks
These Biotechs Are Awaiting FDA Rulings In December
November saw the FDA grant its first emergency use approval for an at-home, self-collected nasal swab test for COVID-19 and approve the first drugs for… Read More »These Biotechs Are Awaiting FDA Rulings In December
“Solid Upside Potential”: 5 Stocks Trading Under $10 For Very Aggressive Investors
“These are five stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential.”
Upside Potential Over 100% Have Analysts “Pounding The Table” On These 3 Stocks
Among the three stocks highlighted in today’s article where analysts at RBC see upside potential over 100% – and which have all earned “Strong Buy” consensus analyst ratings – is “a pharmaceutical company with a unique niche.
“Explosive Growth Potential”: 2 Under-The-Radar Cancer Drugmakers For Risk-Tolerant Investors
Which developmental-stage biotechs have the potential to beat the difficult odds and successfully get their novel drugs to market?
“The Single Best Investment For The Next Decade”
What is this investment opportunity that seems to check all the boxes?
The Case Against These Two Hot COVID-19 Vaccine Stocks
The two biotechs that are the focus of today’s article have been hot this year, with shares of both having experienced triple-digit growth. The reason? Their respective COVID-19 vaccine development programs, which have moved at lightning-fast speed.
“Pour Money Into Your Pocket”: How To Profit From This Soon-To-Be Billion-Dollar Biotech
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
5 Biotech Penny Stocks To Watch Amid An “Unfounded” Time For The Space
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.
Which Biotech Stocks Are Best Positioned To Profit From The Gene Editing Boom?
“Many scientists believe that this year could be a breakthrough in finding cures for cancer in DNA and investors could get familiar with terms like CRISPR and precision medicine to make the most out of advancements in this space.”